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Introduction 1
The three serotypes of poliovirus initiate infection of primate cells by 2 binding to the poliovirus receptor (Pvr, CD155). Interaction of virus and receptor 3 results in conformational changes in the capsid that ultimately lead to release of 4 the viral RNA genome (Racaniello, 2013) . The mechanism by which the receptor 5 interacts with poliovirus has been studied with genetic (Colston and Racaniello, 6 1994 ; Colston and Racaniello, 1995; Liao and Racaniello, 1997 ; Morrison et al., 7 1994 ) and structural approaches (Belnap et Poliovirus is a small, nonenveloped RNA virus with an icosahedral shell 12 composed of 60 copies of the capsid proteins VP1, VP2, VP3, and VP4 (Hogle et 13 al., 1985) . A prominent peak is centered at each fivefold axis of symmetry and a 14 smaller protrusion is near the threefold axis of symmetry. Clusters of 15 neutralization antigenic sites are located on the highly exposed portions of these 16 surface features (Hogle et al., 1985; Page et al., 1988) . A depression or "canyon" 17 that encircles each fivefold axis is the binding site for Pvr, as shown by studies 18 on serotype 1 viruses selected for resistance to soluble receptor (Colston and 19 Monoclonal antibody 711C reacts specifically with domain 1 of Pvr, while 1 monoclonal antibody 55D reacts with an epitope that bridges domains 1 and 2 of 2 Pvr (Morrison et al., 1994) . 3 DNA primers used for site-directed mutagenesis were purchased from the 4 Columbia DNA Facility and GIBCO. The nucleotide that is changed from the wild-5 type sequence is indicated with underline and bold-face. TAT CGT TGA TGG TAT GTC TGT ATG TGG 27mer   22   23   T1022Is  TTG ACA CCA CTG ATA CCT GCC AAC AAC 27mer   24   T1022Ia  GTT GTT GGC AGG TAT CAG TGG TGT CAA  27mer  1   V1056As  ACC AAC CCA TTG GCG CCT TCA GAC ACG  27mer   2   V1056Aa  CGT GTC TGA AGG CGC CAA TGG GTT GGT oligonucleotide was used to prime DNA synthesis on a template consisting of 22 linearized and denatured nectin-2 DNA in a plasmid. The oligonucleotide was 23 phosphorylated at the 5'-end with T4 polynucleotide kinase (New England 24 Biolabs). The templated was denatured by boiling and slowly cooled in the 25 presence of the oligonucleotide, facilitating its annealing to the template. 1
Negative-strand DNA synthesis was completed with Klenow fragment 2 polymerase (New England Biolabs) and the DNA was recircularized with T4 DNA 3 ligase (New England Biolabs). The plasmid DNA was introduced into E. coli 4
DH5α and the desired construct was confirmed by nucleotide sequence analysis. 5
The chimeric nectin-2 DNA insert was excised via Xma I and Pst I restriction 6 sites and subcloned into a 5.3 kb partial digestion product of pMEM brSK7+, 7 which contains the nectin-2 cDNA under the control of an SV40 promoter. 8
Stable L cell transformants synthesizing Pvr or nectin-2 Pvr(c'c"d) were 9 established by the calcium phosphate coprecipitation method as described in 10 (Wigler et al., 1978) . Approximately 10 μg of plasmid DNA encoding the receptor, 11 and 3 μg of plasmids containing either neomycin resistance gene (pcDNANEO, 12 for Pvr transformants) or the herpesvirus thymidine kinase gene (for nectin-13 2 Pvr(c'c"d) transformants) were coprecipitated with calcium phosphate and added to 14 subconfluent monolayers of L tkcells in 10 cm plates. The appropriate drug 15 selection was begun after 48 hours incubation. Two weeks post-selection, single 16 colonies were isolated and subcultured in 24 well plates before expanding into 6 17 cm plates. 18
Cell surface localization of nectin-2 Pvr(c'c"d) could not be detected by 19 available anti-Pvr monoclonal antibodies 711C and 55D (Morrison et al., 1994) , 20
probably because the epitope recognized by these antibodies is not present. Cell 21 clones were therefore screened for susceptibility to infection with poliovirus 22 P1/Mahoney. Cultures that produced a tenfold or greater increase in plaque 23 forming units per ml (PFU) of virus at 24 hours post-infection were scored 24 positive for receptor production. Cell clones that produced the greatest increase 1 in viral yield were subjected to a round of clonal sorting by flow cytometry. These 2 clones were rescreened for susceptibility to infection by poliovirus P1/Mahoney, 3 and the highest producing clones were used for this study. 4
One-step growth analysis and plaque assays 5
For analysis of viral replication, subconfluent monolayers of cells plated in 6 6 cm tissue culture dishes were inoculated with poliovirus at the indicated 7 multiplicity of infection (MOI). After absorption for 30 minutes at 37°C, the plates 8 were washed twice with 4 ml PBS, fresh medium was added and the plates were 9
incubated at 37° C. At the indicated intervals post infection (at t=0 fresh medium 10 is added), cells and supernatant were collected, frozen and thawed three times, 11 and the samples were centrifuged to remove cell debris. Virus titers were 12 determined by plaque assays on HeLa cell monolayers as previously described 13 (Moss et al., 1989) . 14
Selection of viruses that replicate on cells producing the nectin-2 Pvr(c'c"d) 15
receptor. 16 To isolate viruses that replicate on cells synthesizing the nectin-2 Pvr(c'c"d) 17
receptor, approximately 10 7 PFU of P2/Lansing were used to inoculate 18 subconfluent monolayers of L cells synthesizing nectin-2 Pvr(c'c"d) (C2 cells) plated 19 in 6 cm tissue culture dishes. Virus was allowed to adsorb for 30 minutes at 37°C 20 before addition of the agar overlay. Approximately three days post-infection, 21 plaques visualized by colormetric "MTT/INT" assay (Shepley et al., 1988) were 22 isolated with 1ml pipets and virus was eluted from agar plugs in dilution buffer 23 (PBS, 0.2% BCS) overnight at 4°C. Two additional rounds of plaque purification 24 on C2 cells were performed for each isolated virus before seed stocks were 1 established. 2
Cloning and sequencing of the genomic region encoding the viral capsid 3
Poliovirus RNA was isolated from virus isolated by ultracentrifugation, and 4 reverse-transcribed according to methods previously described (La Monica et al., 5 1987 
Metabolic labeling of virus proteins with 35 S-methionine 6
Poliovirus was isotopically labeled according to methods previously 7 described (Morrison et al., 1994) . Three 15 cm plates of semi-confluent HeLa 8 cells were infected at high multiplicity of infection. After a 30 minute adsorption 9 period, growth medium was added, and infection was allowed to proceed for 90 10 minutes at 37°C. The infected monolayers were washed twice with 10 ml PBS, 11
and replaced with methionine-free DMEM supplemented with dialyzed BCS and 12 25 μCi/ml 35 S-methionine (New England Nuclear). After an overnight incubation, 13 cell lysates were collected, clarified by centrifugation at 40,000 rpm at 10°C for 14 90 minutes in an SW41 rotor. The virus pellet was overlaid with 200 μl NTE 15 buffer (10mM NaCl, 50mM Tris-HCl [pH 8.0], 10 mM EDTA) with 0.5% SDS. and 16 incubated overnight at room temperature. The resuspended virus was 17 centrifuged through a 7.5 to 45% sucrose gradient in NTE at 40,000 rpm at 10°C 18 for 75 minutes in a SW41 rotor. Gradients were fractionated from the bottom with 19 a glass capillary tube, and the radioactivity of each fraction was determined by 20 liquid scintillation counting. Peak fractions were pooled and dialyzed against 21
PBS. The number of viral particles per ml was calculated from the absorbance at 22 260 nm, multiplied by the correction factor 9.4 x 10 12 particles per ml (Rueckert, 23 1996) . Purified virus was adjusted to 5 mg/ml bovine serum albumin (BSA, 1 fraction V, Sigma) and stored in 150 to 250 μl aliquots at -70°C. 2
Poliovirus binding assays 3
Virus binding assays were performed with cell monolayers on 6-well 4 plates. Plates were prepared by seeding cells detached with enzyme-free cell 5 dissociation buffer (GIBCO) into duplicate wells at varying density a day before 6 the experiment. After the removal of the medium, cell monolayers were washed 7 twice with PBS, overlaid with labeled virus (2.7 x 10 10 particles) in binding buffer 8 (DMEM, 20% Hepes (GIBCO), 10% BCS), and incubated at the determined 9 temperature. After the time indicated in the figure, unattached viral particles were 10 removed, the cell monolayer were washed and lysed with 0.1N NaOH, and the 11 radioactivity was quantitated by liquid scintillation counting. One plate was set 12 aside for determination of the cell number in the wells. 13
Results 1

Isolation of L cell lines producing Pvr-nectin-2 chimera. 2
Previous studies have demonstrated that mutations located within the C1 and C2, were selected for this study. Mouse L cells do not synthesize Pvr 14 (Mendelsohn et al., 1989) . 15
P1/Mahoney replicates in L cells producing nectin-2 Pvr(c'c"d) 16
Single-step growth analyses were conducted with representatives of each 17 of the three poliovirus serotypes on L cells synthesizing Pvr (20B cells), nectin-18 in C1 and C2 cells, but the kinetics of virus production were different from that in 23 20B cells (Figure 2a ). In 20B cells, after an initial eclipse phase, virus titers increased exponentially to a plateau at approximately 12 hours post-infection. In 1 C1 and C2 cells, the increase in viral titers was more gradual and linear, and did 2 not reach a plateau. Nonetheless, the final titers in C1, C2 and 20B cells were 3 similar. Cytopathic effects typical of poliovirus-infected cells developed in C1 and 4 C2 cells infected with poliovirus P1/Mahoney, although at a slower rate than in 5 20B cells (unpublished data). 6
In contrast to these results, C1 and C2 cells were not susceptible to 7 infection with poliovirus P2/Lansing or P3/Leon ( Figure 2 ). Virus titers observed 8 at different times after infection of C1 and C2 cells with these viruses resembled 9
those observed after infection of nonsusceptible L cells. These results suggest 10 that in contrast to P1/Mahoney, P2/Lansing and P3/Leon cannot recognize the 11 nectin-2 Pvr(c'c"d) receptor. 12
P1/Mahoney binds to chimeric Pvr-nectin-2 cells. 13
To determine if infection of C2 cells correlates with attachment, binding 14 assays were performed. All three serotypes of poliovirus bound to 20B cells, but 15 not to L cells (Figure 3 ). At the highest concentration of cells used, approximately 16 20% of the input P1/Mahoney virus bound to C1 or C2 cells, whereas 60% was 17 bound by 20B cells (Figure 3 ). In contrast, little or no binding of P2/Lansing or 18 P3/Leon to C1 or C2 cells was observed. We conclude that P1/Mahoney can 19 bind to the nectin-2 Pvr(c'c"d) receptor while P2/Lansing and P3/Leon cannot. 20
Selection of P2/Lansing mutants that replicate in cells synthesizing 21
nectin-2 Pvr(c'c"d) . 22
Poliovirus P1/Mahoney formed plaques on monolayers of C2 cells, 23 although the plating efficiency was about 100 to 1000 fold lower than on 20B cells ( Table 1) . Virus stocks with a titer of 10 9 PFU/ml on 20B cells produced an 1 average titer of 10 6 PFU/ml on C2 cells. An additional day of incubation was 2 necessary for plaques to develop on C2 cells. The reduced efficiency of plating 3 and the longer incubation period required for plaque formation are consistent with 4 defects in the viral life cycle observed in the replication assays (Figure 2a ). 5
The efficiency of plaquing of poliovirus P2/Lansing in C2 cells was 6 extremely low (Table 1 ). Viral stocks with a titer of 10 9 PFU/ml on 20B cells 7 yielded 10 1 to 10 3 PFU/ml on C2 cells. To determine whether these plaques were 8
produced by mutant viruses that can replicate in C2 cells, virus was eluted from 9 isolated plaques, subjected to two additional rounds of selection and plaque 10 purification on C2 cells, and viral stocks were generated and titrated on 20B and 11 C2 cells. The titers of the virus isolates on C2 cells were about 10 4 to 10 5 fold 12 greater than the titer of the parental virus ( Table 1) , indicating that they are 13 mutants that can replicate in C2 cells. The titers of the mutant viruses on 20B 14 cells were similar and resembled that of the parent virus. Because the mutant 15 viruses can infect both 20B and C2 cells, they have an expanded host range. 16
Identification of capsid alterations in mutants of P2/Lansing that 17
replicate in cells producing nectin-2 Pvr(c'c"d) . 18 We hypothesized that the mutants of P2/Lansing selected on C2 cells 19 contain amino acid changes in the viral capsid that allow them to recognize the 20 nectin-2 Pvr(c'c"d) receptor. To identify the responsible mutations, DNA encoding the 21 capsid coding sequence was molecularly cloned and its nucleotide sequence 22 was determined. Thirty different amino acid changes at 28 different positions 23 were identified from a total of 24 independent virus isolates ( Table 2) . Many viruses contained one to three mutations, although viruses with four to seven 1 changes were also identified. Six viruses were identified with only one amino acid 2 substitution in the capsid (K1103R, S1239T, or N3059Y). 3 Some mutations appeared in multiple virus isolates ( Table 3 ). The most 4 common change, K1103R, was identified in 21 viruses. Other frequently 5 occurring substitutions were K1169E, S1239T, and G1295E, each identified in 6 six to seven isolates. Three different amino acid changes (N to H, S or Y) were 7 found at a single position, residue 59 in VP3. Although the frequently occurring 8 changes were often on the same viral capsid, there was no distinct pattern of co-9 localization ( Table 2) . All viruses with single or double amino acid changes plaqued efficiently in 21 20B cells and produced titers within one log 10 PFU/ml of P2/Lansing (Figure 4 ). 22
Single substitutions that enable the virus to replicate in C2 cells were K1103R, 23 K1169E, N1235D, S1239T, G1295E, N3059Y, and Q3178H. Viruses with the changes K1103R, N1235D, S1239T, N3059Y, or Q3178H yielded higher titers on 1 C2 cells than viruses with K1169E or G1295E. 2
Multiple changes that were introduced individually into P2/Lansing did not 3 confer the ability to replicate in C2 cells (Figure 4 ). Many of these changes were 4 accompanied by K1103R in the original virus (Table 1 ). Additional viruses were 5 therefore constructed that contain K1103R and one other amino acid change in 6 the capsid. However, in no case was the titer in C2 cells improved by the 7 presence of two amino acid changes in the capsid (Figure 4 ). In two viruses with 8 two changes, E2055G + K1103R and R2076L + K1103R, viral titers on C2 cells 9 were lower than in viruses containing only K1103R. Because viruses containing 10 the single changes E2055G or R2076K did not form plaques on C2 cells, we 11 conclude that other mutations must be necessary to permit growth of the parent 12 viruses containing these substitutions. Unfortunately, it was not practical to test 13 all possible combinations of amino acid changes. 14
Adapting mutations improve binding of P2/Lansing to chimeric Pvr-15
nectin-2. 16
Binding assays were done to determine whether mutations in P2/Lansing 17 that enable it to replicate in C2 cells allow the virus to bind to the nectin-2 Pvr(c'c"d) 18
receptor. In contrast to P2/Lansing, which cannot bind to C2 cells, viruses 19 containing capsid substitutions K1103R, G1295E, S1239T, N3059Y, Q3178H, 20 and K1169E can bind to C2 cells in a cell concentration-dependent manner 21 ( Figure 5 ). The extent of binding of these mutant viruses to C2 cells was 22 comparable to that observed with 20B cells. These results show that certain 23 amino acid changes in the viral capsid allow P2/Lansing to attach to the nectin-1 2 Pvr(c'c"d) receptor, permitting virus entry and replication. 2
The VP1 BC loop is required for viral replication in C2 cells. 3
The results of previous studies have demonstrated that the BC loop of 4 VP1 can regulate receptor recognition and host range (Racaniello, 2013) . Here 5 we find that an amino change at the carboxy terminus of the VP1 BC loop, 6 K1103R, can allow P2/Lansing to bind the nectin-2 Pvr(c'c"d) and was identified in 21 7 out of 24 virus isolates. To assess the importance of the VP1 BC loop in viral 8 growth on C2 cells, we studied viral replication of variants of P1/Mahoney and 9 P2/Lansing with changes in the VP1 BC loop. 10
The results demonstrate that P1/Mahoney requires an intact VP1 BC loop 11 to replicate in C2 cells: a variant of P1/Mahoney from which the VP1 BC loop 12 was deleted, PV-Δ9 virus, did not form plaques on these cells ( Figure 6 ). In Sites of Pvr outside of the C'C"D region that contact poliovirus are derived 8 from nectin-2 in nectin-2 Pvr(c'c"d) , yet, the recombinant receptor can bind to 9 poliovirus P1/Mahoney. Viral capsid residues that interact with these receptor 10 sites may be more tolerant of amino acid changes. Alternatively, the exact amino 11 acid composition at these sites may not be as critical as that of the C'C"D region. 12
Tertiary structures at these sites may be the major determinants of receptor 13 recognition by the capsid. Although the overall amino acid identify between 14 domains 1 of Pvr and nectin-2 is approximately 50%, the distribution of identical 15 amino acid is not uniform throughout the domain; sites outside the C'C"D region 16 account for much of the homology. Homolog-scanning mutagenesis of residues 17 in these sites have been shown not to alter poliovirus P1/Mahoney binding and 18 replication (Morrison et al., 1994) . The observation that nectin-2 Pvr(c'c"d) cannot 19 mediate cell entry of poliovirus serotypes 2 and 3 indicate that nectin-2 amino 20 acids outside of the C'C"D region are not compatible with binding of these 21
viruses. 22
Capsid sequences that regulate receptor binding and entry 1
The inability of poliovirus P2/Lansing to replicate in cells that synthesize 2 nectin-2 Pvr(c'c"d) and the subsequent identification of suppressor mutations affords 3 an opportunity to study capsid residues involved in receptor interaction. The 4 amino acid changes identified in this work are located along the canyon surface, 5 at the protomer interface, and along the canyon perimeter (Figure 7) . The results 6 correlate with previous mutational analyses and structural models derived from It has not been possible to select variants of P2/Lansing that can infect 11 cells producing wild-type nectin-2 (unpublished results). It might be possible to 12 isolate such variants beginning with P2/Lansing mutants adapted to replicate on 13 C2 cells. 14
Amino acid changes in the Pvr contact region on poliovirus. 15
Alterations at capsid residues K1169, N1235, S1239, G1295, and N3059 16 permit P2/Lansing to bind the chimeric receptor (Figure 7) . Changes at these 17 residues may compensate for differences in the receptor chimera that prevent 18 virus binding. Residue K1169 is located in the VP1 EF loop. This loop is at an 19 interface between two fivefold-related protomers and in P1/Mahoney is part of 20 the site on the western canyon wall that makes contact with the G strand of Pvr 21 (Figure 7 ) (Strauss et al., 2015) . Mutations at adjacent residues (E1168G and 22 W1170R) enable P1/Mahoney to utilize mutant Pvr (Liao and Racaniello, 1997) . 23
In poliovirus P1/Mahoney, residue N1235 is located in the VP1 GH loop on the western canyon wall and contacts the Pvr C'C" loop, and residue S1239 is in the 1 H strand and contacts the Pvr FG loop (Strauss et al., 2015) . Nearby residues 2 (A1231, L1234, and D1236) have been previously identified by srr (soluble 3 receptor resistant) mutations as possible receptor contact sites (Colston and 4 Racaniello, 1994) . In P1/Mahoney, A1231 and L1234 contact the C'C" loop of 5
Pvr (Strauss et al., 2015) . 6
Residue G1295 is at the VP1 C-terminus on the eastern canyon wall, and 7 contacts the Pvr CC' loop ( Figure 7 ) (Strauss et al., 2015) . Amino acid N3059 is 8 nearby and is part of the β-strand knob insert that contacts the Pvr EF loop 9 (Strauss et al., 2015) . This region is important in host range determination: Receptor recognition may be influenced not only by residues in the virus-receptor 1 interface, but also by amino acids that regulate capsid flexibility. In solution, the 2 poliovirus capsid is structurally dynamic (Li et al., 1994; Roivainen et al., 1993), 3 and virus binding to the receptor is inhibited at low temperatures by compounds 4 that make the capsid structurally rigid (Dove and Racaniello, 2000) . For example, 5 amino acid change Q3178H, which broadens receptor utilization of P2/Lansing, 6 maps to the same amino acid position as a srr alteration on P1/Mahoney and a ts 7 suppressor in P3/Sabin (Colston and Racaniello, 1994; Filman et al., 1989 ), but 8
does not appear to contact Pvr (Figure 7 ) (Strauss et al., 2015) . Srr viruses with 9 the Q3178L change less readily undergo conversion to noninfectious altered 10 particles upon incubation with receptor. This substitution is thought to render the 11 capsid more rigid, thus increasing its resistance to neutralization by soluble 12 receptors. Conversely, the Q3178H change may cause greater capsid flexibility, 13 thereby facilitating interactions with the less optimal nectin-2 Pvr(c'c"d) receptor. 14 In both P1/Mahoney, which can replicate in C2 cells, and in P3/Leon, 15 which cannot replicate in these cells, the amino acids at position 3178 is 16 glutamine, which was changed to histidine in P2/Lansing selected for growth on 17
C2 cells. 18
Although amino acid S1239C contacts the Pvr FG loop in P1/Mahoney, it 19 may also influence capsid flexibility by altering the structure of the hydrocarbon-20 binding pockets. In P1/Mahoney, a change at position 1241 is associated with 21 the srr phenotype (Colston and Racaniello, 1994) . The change (A1241V) may 22 lead to a conformational shift in the hydrocarbon-binding pocket, resulting in 23 increased resistance to receptor neutralization. In P2/Lansing, residue L1240 occupies the analogous position in lining the hydrophobic pocket (Lentz et al., 1 1997) . By exerting its effects on the neighboring residue, S1239T may indirectly 2 alter the interaction within the hydrocarbon-binding pocket. The changes may 3 enable the virus to achieve the dynamic flexibility necessary for binding the 4 chimeric receptor. 5
K1103R and VP1 BC Loop. 6
The change K1103R is present in 21 of the 28 mutants of P2/Lansing that 7 were studied, suggesting that its presence is highly favored. This amino acid is 8 located along the side of the canyon north wall, at the carboxyl terminal end of 9 the VP1 BC loop (Figure 7 ) (Lentz et al., 1997) . In poliovirus P1/Mahoney, 10 residue K1103 does not make contact with the receptor, although the adjacent 11 residue, D1102, contacts Pvr G strand. In poliovirus type 2 K1103 does not 12 appear to contact Pvr (Zhang et al., 2008) . 13 It is curious that both P1/Mahoney, which can replicate on C2 cells, and 14 P3/Leon, which cannot replicate on these cells, have a lysine at position 1103. 15 P2/Lansing also has a lysine at this position but it changes to arginine after 16 selection for growth on C2 cells. 17
The three-dimensional structure of the VP1 BC loop differs significantly 18 among the serotypes of poliovirus, and in poliovirus P2/Lansing it is structurally 19 disordered (Lentz et al., 1997) . The orientations of amino acid side-chains at 20 residues K1103 and L1104 are reversed between polioviruses P1/Mahoney and 21 P3/Sabin (Yeates et al., 1991) . The structure of the carboxyl terminus of the 22 P2/Lansing VP1 BC loop is more similar to that of P3/Sabin than P1/Mahoney 23 (Lentz et al., 1997) . The difference in the carboxyl terminus of VP1 BC loop may 24 in part be due to the non-conserved amino acid sequence in the BC loop. (Colston and Racaniello, 1995) . This suppressor is not allele specific 17 -it can suppress the effects of mutations at different positions -and the amino 18 acid change is postulated to affect the capsid globally by reducing the thermal 19 requirement for virus binding to Pvr (Dove and Racaniello, 2000) . 20
Our results show that the VP1 BC loop is required for binding of 21 polioviruses P1/Mahoney and P2/Lansing to nectin-2 Pvr(c'c"d) . This observation is 22
surprising in light of the finding that the VP1 BC loop can be deleted without 23 effecting the ability of either virus to bind Pvr and replicate in cultured cells (Martin et al., 1988; Murray et al., 1988) .The VP1 BC loop is therefore not 1 necessary for viral infection of cells producing high affinity, wild-type receptors, 2 but is required for infection of cells synthesizing the low affinity chimeric receptor. Previous genetic analysis of the interaction of poliovirus with Pvr focused 9 largely on serotype 1. In this report, we studied the binding of poliovirus type 2, 10 and our findings extend our understanding of the poliovirus-receptor interaction, 11
identify new sites that regulate receptor binding, and provide additional genetic 12 confirmation for published structural models. We demonstrate that a chimeric 13 protein made up of only a small portion of PVR-specifically, the C'C"D regions--14 in the context of a similar molecule permits viral infection. Serotypic differences in 15 receptor utilization were revealed among the viruses and capsid changes were 16
identified that enabled the virus to overcome the receptor defects. Analysis of 17 these mutations corroborated the location of receptor binding sites predicted from 18 previous genetic and structural data (Figure 7) . 19
The identification of alterations in a receptor binding site on antigenic sites 20 -the VP1 BC loop and the rim of canyon south wall ('knob') -raises interesting 21 questions regarding the restricted antigenic variation observed among poliovirus 22 in comparison to some other members of enterovirus family. Both amino acid 23 changes identified on the 'knob' (G1295 and N3059) are to residues that occur in Microbiology. Columbia University College of Physicians & Surgeons, New York. 23 Colston, E., Racaniello, V.R., 1994. Soluble receptor-resistant poliovirus mutants 24 identify surface and internal capsid residues that control interaction with the cell 25 receptor. EMBO J. 13, 5855-5862. 26 Colston, E.M., Racaniello Color scheme: VP1 is blue, VP2 is yellow, and VP3 is red. VP4, which is internal, 19 is not visualized. Single amino acid changes in VP1 and VP3 that allow poliovirus 20 P2/Lansing to replicate on nectin-2 Pvr (c'c"d) producing cells are shown in white; 21 residues in one structural unit are labeled. One five-fold axis of symmetry is 22 labeled. Western and eastern contact sites on the canyon walls of Pvr on 23 poliovirus P1/Mahoney are indicated by white ovals (Strauss et al., 2015) . The 24 ovals are oriented in the north-south direction on the capsid. The model is based 1 on crystallographic data from Protein Data Bank file 1eah (Lentz et al., 1997) . Table 1 .
Virus titer from cells producing Pvr or nectin-2 Pvr(c'c"d) . 
